ZIVO (Zivo Bioscience) Beta: -0.2480 (As of Jun. 25, 2026)


ZIVO Zivo Bioscience Inc ZIVO
14 GF Score
Price $3.15
! 5 Warning Signs
View Full Analysis

What is Zivo Bioscience Beta?

Zivo Bioscience ZIVO -27.08% 14 Beta is -0.2480 as of Jun. 25, 2026. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Zivo Bioscience's Beta is -0.2480.


Zivo Bioscience  (OTCPK:ZIVO) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Zivo Bioscience Beta Related Terms


Zivo Bioscience Beta Historical Data

* Premium members only.

The historical data trend for Zivo Bioscience's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zivo Bioscience Beta Chart

Zivo Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 -0.36 -0.23 -0.16 1.04

Zivo Bioscience Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 1.04 1.19 0.77 0.33

ZIVO vs INAB, LPCN, CTXR: Beta Comparison

For the Biotechnology subindustry, Zivo Bioscience's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zivo Bioscience Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Beta distribution charts can be found below:

* The bar in red indicates where Zivo Bioscience's Beta falls into.


ZIVO
14GF Score
Zivo Bioscience Inc ZIVO
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zivo Bioscience Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.2480 mean?
Zivo Bioscience (ZIVO) has a Beta of -0.2480 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Zivo Bioscience and its competitors.
Is Zivo Bioscience's Beta too high?
Zivo Bioscience's current Beta is -0.2480. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Beta compare to INAB and LPCN?
Zivo Bioscience's Beta of -0.2480 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Zivo Bioscience and its competitors. Zivo Bioscience's current Beta is -0.2480. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Beta of -0.2480. The current Beta is -0.2480. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Beta is -0.2480 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
14GF Score

Get the complete analysis for ZIVO

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.15
Price